Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5159]

Highlights from AORTIC Cancer Genomics Conference 2021

Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center...

Highlights from AORTIC Cancer Genomics Conference 2021 ( Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center, Accra, Ghana )

Incorporating KRAS as a novel biomarker: Challenges and opportunities

Prof Ales Ryska - Charles University, Prague, Czech Republic

Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )

Real world data and diagnostics in patients with NSCLC with EGFR exon 20...

Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio...

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC...

Prof Andrea Filippi - University of Pavia, Pavia, Italy

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )

Cancer Genomics in Africa today

Dr Solomon Rotimi - Covenant University, Ota, Nigeria

Cancer Genomics in Africa today ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Challenges and solutions in PD-L1 testing in NSCLC

Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France

Challenges and solutions in PD-L1 testing in NSCLC ( Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France )

Managing immune-related adverse events

Catherine Cochez - CHU Strasbourg, France

Managing immune-related adverse events ( Catherine Cochez - CHU Strasbourg, France )

ERAS in gynaecological oncology from developed to developing countries

Prof Geetu Bhandoria - Command Hospital, Kolkata, India

ERAS in gynaecological oncology from developed to developing countries ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)

Dr Giuseppe Giaccone, Dr Marina Garassino

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE) ( Dr Giuseppe Giaccone, Dr Marina Garassino )

Promise of personalised medicine for patients with prostate cancer

Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...

Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )

More from ecancer